According to our (Global Info Research) latest study, the global Prenatal Testing and Newborn Screening Service market size was valued at US$ 6147 million in 2025 and is forecast to a readjusted size of US$ 11840 million by 2032 with a CAGR of 9.9% during review period.
Prenatal Testing and Newborn Screening Service refers to the coordinated clinical services that assess genetic and congenital health risks before birth and identify serious conditions in infants shortly after delivery. It encompasses prenatal risk screening and diagnostic testing during pregnancy, systematic screening of newborns after birth, interpretation and communication of results, confirmatory testing when abnormalities are detected, and referral into timely treatment and long term follow up care.
The prenatal testing and newborn screening service market represents an integrated early life diagnostics segment where clinical value is tightly linked to timing, accuracy, and continuity of care rather than discretionary utilization. Demand is structurally stable because services are embedded in routine obstetric and neonatal care, while competitive dynamics are shaped by regulatory oversight, clinical guidelines, and payer frameworks. The market favors service providers that can operate across the full continuum from prenatal risk assessment to postnatal screening and follow up, as this integration reduces fragmentation and improves clinical decision making. Growth is driven less by volume expansion and more by qualitative upgrades such as broader test menus, improved turnaround time, digital reporting, and coordinated care pathways, reinforcing a market profile that is policy influenced, quality sensitive, and resistant to rapid commoditization.
This report is a detailed and comprehensive analysis for global Prenatal Testing and Newborn Screening Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prenatal Testing and Newborn Screening Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Prenatal Testing and Newborn Screening Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Prenatal Testing and Newborn Screening Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Prenatal Testing and Newborn Screening Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prenatal Testing and Newborn Screening Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prenatal Testing and Newborn Screening Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, Labcorp, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Illumina, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Prenatal Testing and Newborn Screening Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prenatal Testing
Newborn Screening
Market segment by Screening Purpose
Core Condition Screening
Expanded Condition Screening
Market segment by Service Model
Public Health Program
Consumer
Others
Market segment by Application
Public Hospitals
Private Hospitals
Others
Market segment by players, this report covers
Thermo Fisher Scientific
Revvity
Quest Diagnostics
Labcorp
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Illumina
Cordlife
KingMed Diagnostics
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prenatal Testing and Newborn Screening Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prenatal Testing and Newborn Screening Service, with revenue, gross margin, and global market share of Prenatal Testing and Newborn Screening Service from 2021 to 2026.
Chapter 3, the Prenatal Testing and Newborn Screening Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Prenatal Testing and Newborn Screening Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prenatal Testing and Newborn Screening Service.
Chapter 13, to describe Prenatal Testing and Newborn Screening Service research findings and conclusion.
Summary:
Get latest Market Research Reports on Prenatal Testing and Newborn Screening Service. Industry analysis & Market Report on Prenatal Testing and Newborn Screening Service is a syndicated market report, published as Global Prenatal Testing and Newborn Screening Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Prenatal Testing and Newborn Screening Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.